Skip to main content
Premium Trial:

Request an Annual Quote

Tripos Closes Sale of Discovery Research Business

NEW YORK (GenomeWeb News) — Tripos took a step closer to dissolution today after announcing it has closed the sale of its UK-based Discovery Research business to Commonwealth Biotechnologies.
 
The deal, which was penned in May, could be worth a total of $2.15 million depending on certain factors.
 
Tripos President and CEO John McAlister said the sale is “an important step in the completion of the dissolution and liquidation of Tripos and the distribution of the remaining proceeds to our stockholders later this year.”
 
The divestiture makes Tripos a shell company. It will ask the Nasdaq Global Market to delist its shares and will seek to be listed on the OTC Bulletin Board.
 
If the OTC BB is not available, Tripos said it plans to close trading in the company’s stock.

Filed under

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.